查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1586178

細胞解離市場：按產品類型、組織和最終用戶分類 - 全球預測 2025-2030

Cell Dissociation Market by Product (Enzymatic Dissociation Products, Instruments & Accessories, Non-Enzymatic Dissociation Products), Type (Cell Detachment, Tissue Dissociation), Tissue, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年細胞解離市場價值為7.5932億美元，預計到2024年將達到8.786億美元，複合年成長率為16.91%，到2030年將達到22.6764億美元。

細胞解離是指從組織或培養物中釋放細胞的過程，通常透過酵素、化學或機械方法完成。此步驟對於多種應用至關重要，包括用於檢測的細胞製備、單細胞 RNA 定序、幹細胞研究和治療開發。細胞解離的必要性在於它的作用可以讓研究人員和臨床醫生在隔離的環境中研究細胞的行為和功能，從而顯著加深我們對細胞生物學的理解並提高實驗結果的準確性。最終用途包括學術研究、製藥和生物技術行業，特別是在再生醫學和癌症研究中的用途越來越多。

主要市場統計
基準年[2023] 75932萬美元
預測年份 [2024] 8.786 億美元
預測年份 [2030] 22.6764億美元
複合年成長率（%） 16.91%

細胞分離市場受到多種成長要素的推動，包括生物技術的進步、對精準醫療的日益關注以及需要先進治療性介入的慢性疾病盛行率的上升。開發細胞友善的非酶解方法和整合自動化流程以提高效率和重現性存在新的機會。利用這些機會的主要建議包括投資創新解離技術的研發以及與專注於尖端細胞生物學研究的機構建立策略聯盟。

然而，該市場受到與先進解離技術相關的高成本、監管挑戰以及某些解離技術可能影響細胞活力和功能所造成的潛在細胞損傷的限制。隨著公司努力克服這些障礙，對提高解離後細胞存活率的研究和改進技術以最大限度地減少細胞壓力正在推動創新，這是一個充滿可能性的領域。

市場動態是動態的，其特點是技術的快速進步以及研究活動中對永續性和道德考慮的日益重視。調整策略以解決這些領域問題，同時適應監管環境並專注於具有成本效益的解決方案的公司將在這個不斷發展的市場中獲得競爭優勢。

市場動態：揭示快速發展的細胞分離市場的關鍵市場洞察

供需的動態交互作用正在改變細胞分離市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 製藥和生物製藥公司基於細胞的研究活動的擴展
    • 慢性病和感染疾病的發生率和發生率增加
    • 政府資助幹細胞研究活動的情況
  • 市場限制因素
    • 組織和細胞治療方法的高成本
  • 市場機會
    • 持續推出先進的細胞分離產品
    • 細胞解離開發的監管核准增加
  • 市場挑戰
    • 低度開發國家細胞研究基礎設施有限

波特的五力：駕馭細胞分離市場的策略工具

波特的五力框架是了解細胞分離市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解細胞分離市場的外部影響

外部宏觀環境因素在塑造細胞分離市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解細胞分離市場的競爭狀況

細胞分離市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV定位矩陣細胞解離市場供應商績效評估

FPNV定位矩陣是評估細胞解離市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了細胞分離市場的成功之路

細胞分離市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 基於細胞的研究活動在製藥和生物製藥公司中越來越受歡迎
      • 慢性病和感染疾病和盛行率上升
      • 政府資助幹細胞研究活動的情況
    • 抑制因素
      • 基於組織和細胞的治療高成本
    • 機會
      • 持續推出先進的細胞分離產品
      • 細胞解離開發的監管核准增加
    • 任務
      • 開發中國家缺乏細胞研究基礎設施
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章細胞分離市場：依產品

  • 酵素分解產物
    • 膠原酶
    • 去氧核醣核酸酶
    • 彈性蛋白酶
    • 玻糖醛酸酶
    • 木瓜蛋白酶
    • 胰蛋白酶
  • 樂器及配件
  • 非酵素分解產物

第7章細胞分離市場：依類型

  • 細胞脫離
  • 組織解離

第8章 細胞解離市場組織

  • 結締組織
  • 上皮組織
  • 骨骼和肌肉組織

第9章細胞分離市場：依最終用戶分類

  • 製藥和生物技術公司
  • 研究和學術

第10章美洲細胞分離市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太細胞分離市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的細胞解離市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 安捷倫宣布收​​購電子捕獲解離技術公司
    • S2 Genomics 與 Techtum Lab AB 簽署經銷協議，為斯堪的斯堪地那維亞地區提供服務
    • Applied Cells 與 Stem Cell Technologies 簽署下一代細胞分離解決方案所使用試劑組供應協議
    • LevitasBio 宣布 LeviPrep 和 LeviSelect 產品線
  • 戰略分析和建議

公司名單

  • Abeomics Inc.
  • AcceGen
  • ACROBiosystems Group
  • ALSTEM
  • AMS Biotechnology
  • Becton, Dickinson and Company
  • Bio-Techne Corporation
  • Biogenuix Medsystems Pvt. Ltd.
  • Capricorn Scientific
  • Captivate Bio, LLC
  • Cell Signaling Technology, Inc.
  • Cellseco Ltd.
  • Cellsystems Gmbh
  • Celprogen Corporation
  • Central Drug House.（P）Ltd.
  • Corning Inc.
  • Creative Bioarray
  • Cytori Therapeutics Inc.
  • Diagnocine
  • F. Hoffmann-La Roche Ltd.
  • FlowMetric, Inc.
  • Gemini BioProducts LLC
  • Genaxxon bioscience GmbH
  • Genlantis Inc.
  • Genomics, Inc.
  • HiMedia Laboratories Private Limited
  • Innovative Cell Technologies, Inc.
  • Krackeler Scientific, Inc.
  • Merck KGaA
  • Miltenyi Biotec BV & Co. KG
  • MP Biomedicals, LLC
  • Nacalai Tesque, Inc.
  • Neuromics
  • Nordmark Pharma GmbH
  • PAN-Biotech GmbH
  • PELOBIOTECH GmbH
  • PromoCell GmbH
  • Protein Ark Ltd. by CalibreScientific
  • REPROCELL Inc.
  • RWD Life Science Co., Ltd.
  • Sartorius AG
  • ScienCell Research Laboratories, Inc.
  • Singleron Biotechnologies GmbH
  • STEMCELL Group
  • Stemmera Inc.
  • Tebubio
  • Thermo Fisher Scientific Inc.
  • VitaCyte, LLC
  • VWR International, LLC
  • Worthington Biochemical Corporation
Product Code: MRR-46132FF79DDC

The Cell Dissociation Market was valued at USD 759.32 million in 2023, expected to reach USD 878.60 million in 2024, and is projected to grow at a CAGR of 16.91%, to USD 2,267.64 million by 2030.

Cell dissociation refers to the process of releasing cells from tissues or cultures, typically achieved through enzymatic, chemical, or mechanical methods. This procedure is crucial for various applications, including cell preparation for assays, single-cell RNA sequencing, stem cell research, and therapeutic developments. The necessity of cell dissociation lies in its role in enabling researchers and clinicians to study cellular behaviors and functions in isolated environments, which significantly enhances the understanding of cellular biology and improves the accuracy of experimental outcomes. The end-use scope spans academic research, pharmaceutical and biotechnology industries, with expanding use in regenerative medicine and cancer research being particularly notable.

KEY MARKET STATISTICS
Base Year [2023] USD 759.32 million
Estimated Year [2024] USD 878.60 million
Forecast Year [2030] USD 2,267.64 million
CAGR (%) 16.91%

The market for cell dissociation is propelled by several growth factors, including advancements in biotechnology, the increasing focus on precision medicine, and the rising prevalence of chronic diseases that necessitate advanced therapeutic interventions. Emerging opportunities exist in the development of non-enzymatic dissociation methods that are gentler on cells and the integration of automated processes to increase efficiency and reproducibility. Key recommendations to exploit these opportunities include investment in R&D for innovative dissociation technologies and strategic partnerships with institutions focusing on cutting-edge cell biology research.

However, the market faces limitations such as high costs associated with advanced dissociation technologies, regulatory challenges, and potential cell damage caused by certain dissociation techniques that can affect cell viability and functionality. As companies strive to overcome these hurdles, emphasis on research to improve cell viability post-dissociation and the refinement of techniques to minimize cell stress are potential areas of innovation.

The cell dissociation market is dynamic, characterized by rapid technological advancements and a growing emphasis on sustainability and ethical considerations in research practices. Companies that align their strategies to address these areas while navigating regulatory landscapes and focusing on cost-effective solutions stand to gain a competitive edge in this evolving market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Dissociation Market

The Cell Dissociation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of cell based research activities across pharmaceutical and biopharmaceutical companies
    • Rising incidence and prevalence of chronic and infectious diseases
    • Availability of government funding for stem-cell research activities
  • Market Restraints
    • High cost of tissue and cell based procedures
  • Market Opportunities
    • Ongoing introduction of advanced cell dissociation products
    • Rising regulatory approvals for the cell dissociation developments
  • Market Challenges
    • Limited infrastructure for the cell-based research in underdeveloped countries

Porter's Five Forces: A Strategic Tool for Navigating the Cell Dissociation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Dissociation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Dissociation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Dissociation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Dissociation Market

A detailed market share analysis in the Cell Dissociation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Dissociation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Dissociation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell Dissociation Market

A strategic analysis of the Cell Dissociation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Dissociation Market, highlighting leading vendors and their innovative profiles. These include Abeomics Inc., AcceGen, ACROBiosystems Group, ALSTEM, AMS Biotechnology, Becton, Dickinson and Company, Bio-Techne Corporation, Biogenuix Medsystems Pvt. Ltd., Capricorn Scientific, Captivate Bio, LLC, Cell Signaling Technology, Inc., Cellseco Ltd., Cellsystems Gmbh, Celprogen Corporation, Central Drug House. (P) Ltd., Corning Inc., Creative Bioarray, Cytori Therapeutics Inc., Diagnocine, F. Hoffmann-La Roche Ltd., FlowMetric, Inc., Gemini BioProducts LLC, Genaxxon bioscience GmbH, Genlantis Inc., Genomics, Inc., HiMedia Laboratories Private Limited, Innovative Cell Technologies, Inc., Krackeler Scientific, Inc., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, MP Biomedicals, LLC, Nacalai Tesque, Inc., Neuromics, Nordmark Pharma GmbH, PAN-Biotech GmbH, PELOBIOTECH GmbH, PromoCell GmbH, Protein Ark Ltd. by CalibreScientific, REPROCELL Inc., RWD Life Science Co., Ltd., Sartorius AG, ScienCell Research Laboratories, Inc., Singleron Biotechnologies GmbH, STEMCELL Group, Stemmera Inc., Tebubio, Thermo Fisher Scientific Inc., VitaCyte, LLC, VWR International, LLC, and Worthington Biochemical Corporation.

Market Segmentation & Coverage

This research report categorizes the Cell Dissociation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Enzymatic Dissociation Products, Instruments & Accessories, and Non-Enzymatic Dissociation Products. The Enzymatic Dissociation Products is further studied across Collagenase, DNase, Elastase, Hyaluronidase, Papain, and Trypsin.
  • Based on Type, market is studied across Cell Detachment and Tissue Dissociation.
  • Based on Tissue, market is studied across Connective Tissues, Epithelial Tissues, and Skeletal & Muscles Tissues.
  • Based on End-User, market is studied across Pharmaceutical & Biotechnology Companies and Research & Academics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of cell based research activities across pharmaceutical and biopharmaceutical companies
      • 5.1.1.2. Rising incidence and prevalence of chronic and infectious diseases
      • 5.1.1.3. Availability of government funding for stem-cell research activities
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of tissue and cell based procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing introduction of advanced cell dissociation products
      • 5.1.3.2. Rising regulatory approvals for the cell dissociation developments
    • 5.1.4. Challenges
      • 5.1.4.1. Limited infrastructure for the cell-based research in underdeveloped countries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cell Dissociation Market, by Product

  • 6.1. Introduction
  • 6.2. Enzymatic Dissociation Products
    • 6.2.1. Collagenase
    • 6.2.2. DNase
    • 6.2.3. Elastase
    • 6.2.4. Hyaluronidase
    • 6.2.5. Papain
    • 6.2.6. Trypsin
  • 6.3. Instruments & Accessories
  • 6.4. Non-Enzymatic Dissociation Products

7. Cell Dissociation Market, by Type

  • 7.1. Introduction
  • 7.2. Cell Detachment
  • 7.3. Tissue Dissociation

8. Cell Dissociation Market, by Tissue

  • 8.1. Introduction
  • 8.2. Connective Tissues
  • 8.3. Epithelial Tissues
  • 8.4. Skeletal & Muscles Tissues

9. Cell Dissociation Market, by End-User

  • 9.1. Introduction
  • 9.2. Pharmaceutical & Biotechnology Companies
  • 9.3. Research & Academics

10. Americas Cell Dissociation Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cell Dissociation Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cell Dissociation Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Agilent Announces Acquisition of Company Behind Electron Capture Dissociation Technology
    • 13.3.2. S2 Genomics Announces Distribution Agreement with Techtum Lab AB to Serve Scandinavia
    • 13.3.3. Applied Cells Enters into a Supply Agreement with STEMCELL Technologies on Reagent Kits for Use in a Next-Generation Solution for Cell Separation
    • 13.3.4. LevitasBio Unveils LeviPrep and LeviSelect Product Lines
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abeomics Inc.
  • 2. AcceGen
  • 3. ACROBiosystems Group
  • 4. ALSTEM
  • 5. AMS Biotechnology
  • 6. Becton, Dickinson and Company
  • 7. Bio-Techne Corporation
  • 8. Biogenuix Medsystems Pvt. Ltd.
  • 9. Capricorn Scientific
  • 10. Captivate Bio, LLC
  • 11. Cell Signaling Technology, Inc.
  • 12. Cellseco Ltd.
  • 13. Cellsystems Gmbh
  • 14. Celprogen Corporation
  • 15. Central Drug House. (P) Ltd.
  • 16. Corning Inc.
  • 17. Creative Bioarray
  • 18. Cytori Therapeutics Inc.
  • 19. Diagnocine
  • 20. F. Hoffmann-La Roche Ltd.
  • 21. FlowMetric, Inc.
  • 22. Gemini BioProducts LLC
  • 23. Genaxxon bioscience GmbH
  • 24. Genlantis Inc.
  • 25. Genomics, Inc.
  • 26. HiMedia Laboratories Private Limited
  • 27. Innovative Cell Technologies, Inc.
  • 28. Krackeler Scientific, Inc.
  • 29. Merck KGaA
  • 30. Miltenyi Biotec B.V. & Co. KG
  • 31. MP Biomedicals, LLC
  • 32. Nacalai Tesque, Inc.
  • 33. Neuromics
  • 34. Nordmark Pharma GmbH
  • 35. PAN-Biotech GmbH
  • 36. PELOBIOTECH GmbH
  • 37. PromoCell GmbH
  • 38. Protein Ark Ltd. by CalibreScientific
  • 39. REPROCELL Inc.
  • 40. RWD Life Science Co., Ltd.
  • 41. Sartorius AG
  • 42. ScienCell Research Laboratories, Inc.
  • 43. Singleron Biotechnologies GmbH
  • 44. STEMCELL Group
  • 45. Stemmera Inc.
  • 46. Tebubio
  • 47. Thermo Fisher Scientific Inc.
  • 48. VitaCyte, LLC
  • 49. VWR International, LLC
  • 50. Worthington Biochemical Corporation

LIST OF FIGURES

  • FIGURE 1. CELL DISSOCIATION MARKET RESEARCH PROCESS
  • FIGURE 2. CELL DISSOCIATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CELL DISSOCIATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELL DISSOCIATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CELL DISSOCIATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CELL DISSOCIATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CELL DISSOCIATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CELL DISSOCIATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CELL DISSOCIATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CELL DISSOCIATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CELL DISSOCIATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CELL DISSOCIATION MARKET DYNAMICS
  • TABLE 7. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELL DISSOCIATION MARKET SIZE, BY COLLAGENASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CELL DISSOCIATION MARKET SIZE, BY DNASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELL DISSOCIATION MARKET SIZE, BY ELASTASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CELL DISSOCIATION MARKET SIZE, BY HYALURONIDASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PAPAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TRYPSIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CELL DISSOCIATION MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELL DISSOCIATION MARKET SIZE, BY NON-ENZYMATIC DISSOCIATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CELL DETACHMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TISSUE DISSOCIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CONNECTIVE TISSUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CELL DISSOCIATION MARKET SIZE, BY EPITHELIAL TISSUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CELL DISSOCIATION MARKET SIZE, BY SKELETAL & MUSCLES TISSUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CELL DISSOCIATION MARKET SIZE, BY RESEARCH & ACADEMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. CELL DISSOCIATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. CELL DISSOCIATION MARKET, FPNV POSITIONING MATRIX, 2023